Related Experiment Video
Updated: May 27, 2025

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.0K
Understanding HLA-DQ in renal transplantation: a mini-review
Rajdeep Das1, Neil S Greenspan1
1University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Frontiers in Immunology
|February 20, 2025
Summary
High-resolution human leukocyte antigen (HLA) typing is crucial for assessing HLA-DQ mismatches, improving donor-specific antibody (DSA) prediction, and personalizing transplant outcomes. Advanced methods refine risk evaluation beyond traditional typing limitations.
Area of Science:
- Transplantation immunology
- Immunogenetics
Background:
- Human leukocyte antigen (HLA) mismatching, especially HLA-DQ, is a major driver of donor-specific antibodies (DSA) and adverse transplant outcomes.
- Traditional HLA typing methods often misclassify mismatches, hindering accurate immunogenicity assessment and clinical risk stratification.
Purpose of the Study:
- To highlight the critical role of advanced high-resolution HLA typing in improving the assessment of HLA-DQ mismatches.
- To discuss the limitations of current typing methods and the potential of emerging molecular mismatch algorithms.
Main Methods:
- Review of current literature on HLA mismatching, immunogenicity, and typing technologies.
- Analysis of the impact of amino acid differences, evolutionary divergence, and HLA-DQ expression complexities on T-cell alloreactivity and DSA development.
Main Results:
- High-resolution HLA typing offers superior mismatch assessment compared to traditional methods.
- Molecular mismatch algorithms and analysis of evolutionary factors show promise but require further validation for predicting individual patient outcomes.
- HLA-DQ expression variability, including heterodimer formation and alternative splicing, complicates risk evaluation.
Conclusions:
- Advanced high-resolution HLA typing is essential for refining graft selection, DSA monitoring, and personalized therapy in transplantation.
- Further research into the precise mechanisms of HLA-DQ immunogenicity is needed to advance transplantation science and improve patient outcomes.
Related Concept Videos
Tissue Transplantation
331
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
331
Bone Marrow Sampling and Transplants
275
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
275

